- Home
- DNLI vs ABR Comparison
DNLI vs ABR Comparison
Compare DNLI & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- ABR
- Stock Information
- Founded
- DNLI 2013
- ABR 2003
- Country
- DNLI United States
- ABR United States
- Employees
- DNLI N/A
- ABR N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- ABR Real Estate Investment Trusts
- Sector
- DNLI Health Care
- ABR Real Estate
- Exchange
- DNLI Nasdaq
- ABR Nasdaq
- Market Cap
- DNLI 3.3B
- ABR 2.7B
- IPO Year
- DNLI 2017
- ABR 2004
- Fundamental
- Price
- DNLI $21.43
- ABR $13.74
- Analyst Decision
- DNLI Strong Buy
- ABR Hold
- Analyst Count
- DNLI 11
- ABR 6
- Target Price
- DNLI $40.40
- ABR $14.25
- AVG Volume (30 Days)
- DNLI 815.8K
- ABR 1.8M
- Earning Date
- DNLI 11-06-2024
- ABR 11-01-2024
- Dividend Yield
- DNLI N/A
- ABR 12.53%
- EPS Growth
- DNLI N/A
- ABR N/A
- EPS
- DNLI N/A
- ABR 1.35
- Revenue
- DNLI N/A
- ABR $650,354,000.00
- Revenue This Year
- DNLI N/A
- ABR N/A
- Revenue Next Year
- DNLI $420.35
- ABR N/A
- P/E Ratio
- DNLI N/A
- ABR $10.18
- Revenue Growth
- DNLI 204.74
- ABR N/A
- 52 Week Low
- DNLI $14.56
- ABR $11.92
- 52 Week High
- DNLI $33.33
- ABR $16.35
- Technical
- Relative Strength Index (RSI)
- DNLI 31.13
- ABR 42.79
- Support Level
- DNLI $22.61
- ABR $14.14
- Resistance Level
- DNLI $24.15
- ABR $14.55
- Average True Range (ATR)
- DNLI 1.09
- ABR 0.28
- MACD
- DNLI -0.15
- ABR 0.01
- Stochastic Oscillator
- DNLI 7.59
- ABR 28.13
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.